Abstract. Licochalcone B (Lico B), which belongs to the retrochalcone family, is isolated from the roots of Chinese licorice. Lico B has been reported to have several other useful pharmacological properties, such as anti-inflammatory, antibacterial, antioxidant, antiulcer, anticancer, and anti-metastasis activities. We elucidated the underlying mechanism by which Lico B can induce apoptosis in oral squamous cell carcinoma (OSCC). Our results showed that exposure of OSCC cells (HN22 and HSC4) to Lico B significantly inhibited cell proliferation in a timeand concentration-dependent manner. Lico B caused cell cycle arrest at G1 phase along with downregulation of cyclin D1 and upregulation of p21 and p27 proteins. Lico B also facilitated the diffusion of phospholipid phosphatidylserine (PS) from inner to outer leaflets of the plasma membrane with chromatin condensation, DNA fragmentation, accumulated sub-G1 population in a concentration-dependent manner. Moreover, Lico B promoted the generation of reactive oxygen species (ROS), which, in turn, can induce CHOP, death receptor (DR) 4 and DR5. Lico B treatment induced downregulation of anti-apoptotic proteins (Bid and Bcl-xl and Mcl-1), and up regulation of pro-apoptotic protein (Bax). Lico B also led to the loss of mitochondrial membrane potential (MMP), resulting in cytochrome c release. As can be expected from the above results, the apoptotic protease activating factor-1 (Apaf-1) and survivin were oppositely expressed in favor of apoptotic cell death. This notion was supported by the fact that Lico B activated multi-caspases with cleavage of poly (ADP-ribose) polymerase (PARP) protein. Therefore, it is suggested that Lico B is a promising drug for the treatment of human oral cancer via the induction of apoptotic cell death.
Introduction
Oral squamous cell carcinoma (OSCC), accounting for over 90% of head and neck cancers, is the most common malignancy of oral cavity cancers, with more than half a million new patients diagnosed annually, and metastasis to lymph node frequently takes place (1) (2) (3) . Since most patients are diagnosed with OSCC after the cancer has progressed to an advanced stage, the 5-year survival rate remains low (4, 5) . In spite of great advances of early diagnosis and cancer treatment, the 5-year survival rate for patients with OSCC remains <50% and has not improved over the last few decades (3) . Consequently,
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there is a need for development of effective therapeutic agents that could prevent and treat OSCC.
Herbal medicine has been regarded as an alternative approach to modern medicine and there have been various efforts to find active components with better anticancer potency and less side effects (6) . Licorice, the root and rhizome of several Glycyrrhiza species (Leguminosase) (7) , has been used as a flavouring agent, and traditional medicine for gastric ulcer, bronchial asthma and inflammation (8) . There have been many studies on the biological effects of active ingredients of licorice, such as anti-inflammatory, anti-microbial, antioxidative, antiulcer, cytoprotective and cytotoxic activities (9) . Licochalcone B (Lico B), a chalconoid presents in the root of Glycyrrhiza species, not only inhibit cell proliferation, but also to induce cell cycle arrest and apoptosis (10) . Possibly, Lico B could be a promising alternative compound to traditional anticancer agents.
Apoptosis (programmed cell death), triggers an extrinsic (death receptor-mediated signaling) or an intrinsic (mitochondria-mediated signaling) pathway to activate caspase-3, leading to morphological alterations (e.g., DNA fragmentation, cell shrinkage, membrane blebbing and chromatin condensation) (11, 12) . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the TNF cytokine superfamily, interacts with five different receptors to coordinate cancer cell apoptosis. Among these receptors, only death receptor (DR)4 and DR5 have cytoplasmic death domains and are able to transduce the apoptotic signal of TRAIL by association with the Fas-associated death domain (FADD) protein, transmitting the apoptotic death signals into the cancer cells (13) . Activation of caspase-8 causes cleavage of Bid and Bcl-2 family proteins and induces releasing of cytochrome c from mitochondria to cytosol. The mitochondria-mediated pathway is regulated by Bcl-2 family proteins such as Bax and Bak. Apoptotic induction is accompanied by the release of cytochrome c from mitochondria, which mediate apoptosis in both the extrinsic and intrinsic pathways. The resulting cytochrome c forms the apoptosome with apoptotic protease activating factor-1 (Apaf-1), ATP and procaspase-9 (14) . Thus, many studies have shown that the induced expression of DR4 and DR5 contributes to apoptosis caused by cancer drugs (13) . Moreover, reactive oxygen species (ROS) induce endoplasmic reticulum (ER) stress-induced apoptosis via modulation of CCAAT/enhancerbinding protein homologous protein (CHOP) (14, 15) . That is, overexpression of CHOP promotes apoptosis through downregulation of cell survival proteins and upregulation of DR4 and DR5 (16, 17) .
However, mechanism of Lico B-induced apoptosis in OSCC have not been well defined. This study suggests that Lico B inhibits cell growth and induces apoptosis in OSCC HN22 and HSC4 cells.
Materials and methods

Reagents and antibodies.
We prepared Lico B with 95% purity according to the method previously reported (18) . Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), trypsin, penicillin and streptomycin (P/S) and phosphatebuffered saline (PBS) were purchased from Thermo Scientific (Logan, UT, USA). Antibodies against cyclin D1, p21, p27, DAPI staining. After treatment with Lico B, the HN22 and HSC4 cells were harvested by trypsin digestion. The cells were washed in ice-cold PBS and fixed with 100% methanol at room temperature (RT) for 1 h. Fixed cells were stained with DAPI solution (2 µg/ml) and deposited on slides at RT in the dark. DAPI-stained cells were observed through a FluoView confocal laser microscope (Flouview FV10i, Olympus Corp., Tokyo, Japan). Western blotting. The cell lysates were prepared using PRO-PREP™ Protein Extraction Solution (iNtRON Biotechnology, korea) and then supernatants were collected by centrifugation. Samples containing equal amounts of protein were separated by SDS-PAGE and transferred to poly vinylidene difluoride membrane. The membranes were blocked with 5% skim milk in PBS with 0.1% Tween-20 at RT. Membranes were probed with primary antibodies at 4˚C overnight with mild shaking and then washed with PBST for a total of 30 min. Finally, membranes were incubated with the secondary antibodies for 2 h at RT. Antibody-bound protein bands were visualized using ECL Plus Western Blotting Detection system (Santa Cruz Biotechnology, Inc.). added to each sample. Multi-caspase assay was performed with Muse Cell Analyzer (Merck Millipore).
Statistical analysis. Using Student's t-test, the statistical significance was assessed. The result with p-value <0.05, indicates statistical significance of data.
Results
Inhibition of cell proliferation by Lico B.
Trypan blue staining was performed to determine the viability of HN22 and HSC4 cells treated with Lico B (0, 10, 20 and 30 µM) for 24 and 48 h, and then live cells were counted using a haemocytometer. As shown in Fig. 1A , cell viability was significantly decreased in a concentration-and time-dependent manner by Lico B (Fig. 1A) . The IC 50 value was 15 µM for HN22 cells and 13 µM for HSC4 cells at 48 h. Cell morphology was observed under an inverted phase contrast microscope after the cells were treated with Lico B for 48 h, and images were obtained (Fig. 1B) . Significant cell shrinkage, formation of plasma membrane blebs and a decreased cellular attachment rate were observed in the Lico B-treated groups. These results suggest that Lico B has an inhibitory effect on the cell growth of HN22 and HSC4 cells.
Lico B induces apoptosis in HN22 and HSC4 cells.
Phosphatidylserine (PS) of normal cells are mainly distributed on the inner layer of the membrane. However, early apoptotic cells transpose PS on the outer layer of the membrane (20) . Annexin V can detect PS on the outer membrane, designating early apoptotic cells while 7-AAD can permeate into plasma membrane and bind to DNA when the membrane of cells lose integrity. Annexin V and 7-AAD absorb laser with different wavelengths so that both fluorophores can be analyzed at (Fig. 1C, left) . In HSC4, population of apoptotic cells was 36.63±3.33, 60.92±3.01, 83.36±1.43% at 10, 20 and 30 µM of Lico B, respectively (Fig. 1C, right) . Additionally, the characteristic appearance of apoptosis was analyzed by DAPI staining. HN22 and HSC4 cells treated with Lico B presented nuclear shrinkage, chromatin condensation and fragmentation of nuclear bodies compared to control (Fig. 2A) . The cell cycle distribution was assessed after PI staining by Muse Cell Analyzer. As shown in Fig. 2B , the treatment of cells with Lico B at 30 µM caused 36.83±3.85 or 39.37±0.6% induction of sub-G 1 phase in HN22 (Fig. 2B, left) and HSC4 (Fig. 2B, right) , respectively. Overall, these findings suggest that Lico B can induce apoptosis in HN22 and HSC4 cells.
Lico B induces G 1 phase arrest in HN22 and HSC4 cells.
To determine the effect of Lico B on the cell cycle progression, HN22 and HSC4 cells were treated with different concentrations of Lico B (0, 10, 20 and 30 µM) for 48 h and the cell cycle distribution was assessed by Muse Cell Analyzer. Fig. 2B showed that HN22 and HSC4 cells accumulated in G 1 phase after treatment of Lico B (Fig. 2B) . To confirm G 1 block in cell cycle progression, the level of G 1 cell cycle components was monitored by western blot analysis. Fig. 2C showed that Lico B increased the protein levels of p21 and p27, and decreased the levels of cyclin D1 (Fig. 2C) . These results support that Lico B causes G 1 phase arrest in OSCC cells. Overwhelming ER stress resulted from accumulation of ROS has been known to trigger apoptotic signaling (15, 21) . As shown in Fig. 3A , ROS production from HN22 and HSC4 cells treated with Lico B was significantly increased. CHOP is one of the components of ER stress-mediated apoptosis pathway (16) . To assess the effect of Lico B on CHOP expression in HN22 and HSC4 cells, western blotting was performed. Fig. 3B showed that the protein levels of CHOP were increased in a dose-dependent manner by Lico B. CHOP is suggested to induce apoptosis through upregulation of DR4 and DR5 expression (16) . We also observed that Lico B treatment increased dose-dependently DR4 and DR5 in HN22 and HSC4 cells (Fig. 3B) . These results showed that treatment of OSCC cells with Lico B induced ER stress, which, in turn, upregulates CHOP, DR4 and DR5.
Lico B induces endoplasmic reticulum (ER) stress and expression of death receptor (DR) 4, DR5 in HN22 and HSC4 cells.
Lico B modulates the level of proteins related to apoptosis in HN22 and HSC4 cells. Dynamic changes in Bcl-2 family proteins were associated with death receptor-mediated apoptosis (22) . Bcl-xl functions as an anti-apoptotic protein, whereas Bax is pro-apoptotic protein (23) . Bid is then truncated to induce apoptosis. Downregulation of Mcl-1 protein may be required to initiate a cascade of apoptotic signals leading to release of cytochrome c (5). To investigate whether expression of apoptosis regulatory proteins may be modulated by Lico B, the protein levels of Bid, Bax, Bcl-xl and Mcl-1 in HN22 and HSC4 cells treated with Lico B were analyzed by western blotting. Fig. 3C showed that the levels of pro-apoptotic Bax were increased and the expression levels of Bid, Bcl-xl and Mcl-1 were decreased in a concentration-dependent manner. (Fig. 4A) . The loss of MMP leads to the release of cytochrome c into the cytosol then, triggering the downstream processes in the apoptotic cascade (26) . To examine whether Lico B could cause the release of cytochrome c into the cytosol, subcellular distribution of cytochrome c in cytosol and mitochondria fraction were analyzed by western blotting. The results showed that cytochrome c in cytosol fraction of HN22 and HSC4 cells treated with Lico B (0, 10, 20 and 30 µM) was concentrationdependently increased (Fig. 4B) . These results indicated that Lico B facilitated mitochondrial membrane depolarization and release of cytochrome c into the cytosol. Additionally, to investigate downstream target proteins including Apaf-1, survivin and PARP in mitochondria-mediated apoptosis, their expression was analyzed by western blotting with specific antibodies. As shown in Fig. 4B , the expression levels of survivin and PARP were diminished, but Apaf-1 and C-PARP were increased in a concentration-dependent manner by Lico B.
Lico B induces mitochondrial membrane depolarization and mitochondria-mediated apoptosis in OSCC cells
Lico B induces caspase-mediated apoptosis in HN22 and HSC4 cells. To examine whether Lico B-induced apoptosis would be associated with the activation of caspases, the expression levels and activity of caspases such as caspase-1, -3, -4, -5, -6, -7, -8 and -9 in the Lico B-treated OSCC cells were assessed using Muse Cell Analyzer. As shown in Fig. 5 , HN22 and HSC4 cells treated with Lico B exhibited enhanced multi-caspase activity in a concentration-dependent manner. The multi-caspase activity of HN22 cells (Fig. 5, left) was 4.33±0.76, 34.09±2.07 and 81.1±2.86%, respectively, at 10, 20 and 30 µM of Lico B compared with control. In HSC4 cells (Fig. 5, right) , multi-caspase activity was 10.08±0.85, 38.5±2.25 and 74.29±2.81% at 10, 20 and 30 µM of Lico B, respectively.
Discussion
Natural extracts derived from edible plants have been investigated as alternative products of cancer drugs based on safety and efficacy (27) . Chalcones are ubiquitous natural products with a wide variety of reported biological activities such as antiviral, anti-microbial, anti-inflammatory and anti-cancer effect (6, 28) . Recent studies have reported that Lico B, a chalcone extracted from licorice, inhibits cell proliferation and induces cell cycle arrest and apoptosis in tumor cells (6) . Lico B has been reported to attenuate bladder cancer cell migration, adhesion and invasion by downregulating the protein expression and suppressing the activity of matrix metalloproteinase 9 (10) .
Oral squamous cell carcinoma (OSCC) is the most common neoplasm of oral cavity cancers (4) . Despite great advances in cancer diagnosis and therapy, there has been little improvement in the 5-year survival rate of oral cancer patients (27) . Anticancer effects of the Lico B have been reported in a variety of cancers, but has not been examined previously in OSCC. To better understand the action mechanisms of Lico B on OSCC cell lines, we further checked the intracellular signaling pathway. We found that Lico B induced apoptosis by intrinsic and extrinsic apoptotic pathways in HN22 and HSC4 cells. We found that Lico B significantly not only inhibited cell growth in a concentration-and timedependent manner, but also induced apoptosis in OSCC cells (HN22 and HSC4) .
The morphological alterations such as cell shrinkage, chromatin condensation and DNA fragmentation supported Lico B-induced apoptotic induction. p21 and p27 proteins are members of the Cip/kip family, and regulate cell cycle progression (29) . Cyclin D1 is a key protein at G 1 phase in the cell cycle progression. This protein dimerizes with CDk4/6 to regulate the G 1 /S phase transition and enter the S phase. Thus, cyclin D1 is involved in the development and progression of various tumors (30) . Our results showed that percentage of cells was increased in the sub-G 1 phase during Lico B treatment, arresting in G 1 phase. In OSCC cells, Lico B inhibits cell cycle progression as a result of reduced cyclin D1, and increased p21 and p27 expression. Deregulation of the cell cycle is frequent during cancer development (6) . Therefore, inhibition of cell cycle progression is considered as useful approach to control of cancer cell growth.
In several studies, phytochemicals exhibited anticancer activities by the activation of death receptor and loss of MMP in tumor cells (31) , and anticancer agents can enhance ROS production associated with apoptosis in cells (32) . ER stress-induced response mediates the expression of the apoptosis-relevant gene such as CHOP, DR4 and DR5 (15, 33) . CHOP plays a decisive role in the expression of death receptor (17) . Our results indicated that Lico B induced DR4 and DR5 expression through regulation of ROS-CHOP mediated pathway. The results suggest that Lico B induces apoptosis through the extrinsic pathway. The expression of Bcl-2 family proteins is directly linked to cell damage and there are important factors that make up the apoptosome (34) . The mitochondrial function has been reported to be regulated by Bcl-2 family proteins such as anti-apoptotic (Bcl-2, Bcl-xl and Mcl-1) and pro-apoptotic (Bax, Bad and Bak) proteins (35) . Thus, changes in the levels of Bcl-2 family proteins can affect the mitochondrial physiology positively or negatively (36) . The results showed that Lico B led to downregulation of anti-apoptotic Bid, Bcl-xl and Mcl-1, and upregulation of proapoptotic Bax. Subsequently, Lico B resulted in a significant decrease in the level of MMP and release of cytochrome c from mitochondria to cytosol, finally executing cell death by activation of caspases (37) .
The release of cytochrome c into the cytosol is regulated by the equilibrium between anti-apoptotic and pro-apoptotic proteins and plays an important role in the execution of apoptosis (26, 34) . Additionally, Lico B treatment increased the expression of Apaf-1 and cleavage of PARP, while it decreased inhibitor of apoptosis (IAP) family proteins (survivin) which are direct inhibitors of activated caspases (38) . The activation of Bax and caspase is critical for initiation and amplification of apoptosis, and their activation is normally blocked by Bcl-xl or IAP proteins (6) . All these studies support that Lico B also induces apoptosis through the intrinsic pathway.
In summary, this study demonstrated that Lico B induced apoptosis in OSCC cells. Apoptosis was triggered through the extrinsic pathway by upregulating death receptor and also the intrinsic pathway by modulating Bcl-2 and IAP family members. These findings provide the underlying molecular mechanisms for the anticancer effects of Lico B that can be useful in the treatment of human oral cancer.
